Patent · US Active

Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer

US8685398B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Biokine Therapeutics Ltd. · IL

Inventors

Michal Abraham · Mevaseret Tsiyon, IL
Orly Eizenberg · Rehovot, IL
Amnon Peled · Tel Aviv-Yafo, IL

Key dates

Filing date	Jun 15, 2010
Grant date	Apr 1, 2014
Priority date	—
Expiry date	Jun 15, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel polypeptides comprising a chemokine-binding peptide and an Fc fragment are disclosed. The polypeptides are capable of binding to certain chemokines so as to modulate their activity. These polypeptides can be used to modulate in vivo chemokine-dependent processes such as inflammation and autoimmunity, and to treat associated conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.